Lung Cancer

Radiation therapy is the most common treatment for lung cancer, the most frequently diagnosed type of cancer worldwide.

Patients who received sublobar resection for early-stage non-small cell lung cancer had similar 5-year DFS rates compared with those who underwent lobectomy, according to results of a randomized phase 3 study.

Risk-based strategies for lung cancer screening were more cost-effective than screening based on age and smoking history as recommended by the U.S. Preventive Services Task Force, a recent study found.

Asian and Black patients with lung cancer experienced longer delays to radiation treatment than their white counterparts, according to study results published in Health Equity.

Climate change and cancer share a root cause — our reliance on fossil fuels, according to Leticia M. Nogueira, PhD, MPH.

Tarlatamab showed encouraging response durability among heavily pretreated patients with small cell lung cancer, according to study results.

The addition of serplulimab to chemotherapy extended OS among patients with previously untreated extensive-stage small cell lung cancer, according to randomized phase 3 study results.

Frequent postoperative surveillance imaging after lung cancer resection did not improve outcomes for patients with stage I non-small cell lung cancer, according to data published in Journal of the National Cancer Institute.

An artificial intelligence tool predicted a person’s lung cancer risk after analyzing a single low-dose CT scan, according to study results.

The FDA approved pembrolizumab as adjuvant treatment for patients with stage IB, stage II or stage IIIA non-small cell lung cancer after resection and platinum-based chemotherapy.